"I love UICC | Leading the global fight against cancer"

2022-05-04 17:52:50

Jump to navigation Join the conversation Social live stream Our Community UICC twitter facebook instagram youtube linkedin UICC Leading the global fight against cancer Who we areAbout UICCCancer controlAreas of workStrategyAnnual ReportsRecognition and awardsHistory of UICCUICC and TNMEquity and gender equality at UICCCEOBoard of DirectorsPresidentPresident-electThe TeamEmploymentHead of EventsHead of Partnership DevelopmentOther opportunitiesPress centre About UICC"The Union for International Cancer Control (UICC) unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda."Read more Spotlight onWelcometo one of our new membersFundación ChilesincáncerRead more EmploymentWe are currently looking for a Head of Events and Head of Partnership Development.View all employment opportunities What we doConveningWorld Cancer DayWhy WCD MattersThe CampaignWorld Cancer Congress2022 World Cancer CongressPast CongressesWorld Cancer Leaders' Summit2021 World Cancer Leaders' SummitSummit ProgrammeSummit SpeakersOutstanding Contribution to Cancer Control AwardsShortlisted nominees2019 World Cancer Leaders' SummitSummit ProgrammeSide eventsOutstanding Contribution to Cancer Control AwardPast Summits2018 World Cancer Leaders' Summit2017 World Cancer Leaders' SummitOfficial Side Events2016 World Cancer Leaders' SummitHost a World Cancer Leaders' SummitRoundtable SeriesCalendar of cancer eventsVirtual DialoguesAgeing and Cancer seriesBreast Cancer seriesCancer beyond COVID-19 seriesCervical Cancer Elimination seriesLeading questions seriesRegional seriesTobacco Control and Cancer seriesPast Dialogues Resource HubCapacity BuildingGrantsBreast cancer grantsSPARC MBC ChallengeSelection Advisory GroupMetastatic Breast CancerSPARC mentorsFellowshipsVirtual FellowshipsTechnical FellowshipBourses pour l’Afrique FrancophoneYY Study GrantsFellowship Outcomes and ImpactAssociation of UICC FellowsPast successesLeadershipYoung Leaders programmeYoung Leaders 2021/2022Young Leaders 2019/2020Young Leaders AlumniOnline learningMaster coursesAdvocacy for improved cancer controlFuture-proofing cancer organisations for uncertain and fast-changing timesLaw and policy for cancer prevention and controlRaising the voices of patient advocatesSelf-guided coursesCancer Advocates programmePatient Group Mentoring programmeRegional engagementAdvocacyAdvocacy ImpactInteractive navigatorCancer planningWorld Cancer DeclarationWorking togetherGlobal Initiative for Childhood CancerIntegrated Cancer Control Initiative in Latin America (ICCI-LA)International Collaboration on Nutrition in relation to Cancer (ICONIC)UICC Advocacy NetworkAdvocacy resourcesThematic areas of workAntimicrobial resistanceUICC's actions on AMRAntimicrobial resistance resourcesBreast cancerUICC’s actions on breast cancerBreast cancer resourcesBreast Cancer ProgrammeCancer and AgeingCancer and COVID-19Cancer and COVID-19 resourcesCervical cancer eliminationUICC's actions on cervical cancerCervical cancer resourcesFinancing for cervical cancer eliminationEssential Medicines ListTobacco controlTobacco control resourcesWorld No Tobacco DayUniversal Health CoverageInvesting in cancer control Virtual DialoguesVirtual Dialogues provide members with enhanced opportunities to connect, exchange knowledge, access expert insights, and more.Read more Young Leaders programmeUICC aims to nurture aspiring young cancer control professionals to become successful leaders in cancer control and the wider global health community.Read more World Cancer DeclarationIts overarching goal: major reductions in premature deaths from cancer, and improvements in quality of life and cancer survival rates.Read more Who we work withMembersOur membership offerMembership categories and benefitsBecome a memberRenew membershipApply for membershipMap of membersGeneral Assembly2020 GAOn-line voting at UICC's first virtual General Assembly2020-2022 Board of Directors and President-elect candidates' profilesRecent Constitutional changesPast General AssembliesUICC AwardsUICC Awards: 2022 Best CEO AwardUICC Awards: 2022 Best WCD Campaign AwardUICC Awards: 2020 Winners and FinalistsUICC Awards: 2018 Winners and FinalistsUICC NewsletterMembers' CornerPartnersOur partnersPartners news and blog articlesPartner testimonialsBecome a partnerNetworksCity Cancer Challenge (C/Can)NCD AllianceInternational Cancer Control Partnership (ICCP)McCabe Centre for Law and CancerGlobal Initiative for Cancer Registries (GICR)UICC responding to the call to action to eliminate cervical cancerMembers response to call to action to eliminate cervical cancer Become a memberAre you interested in joining a dynamic network of over 1,000 members that share a passion to eliminate cancer as a life-threatening disease for future generations. Join us today:Apply for membership Become a partner Through our proven track record of success, UICC is able to bring influential stakeholders together, and we invite you to be part of this journey and help us drive change globally. Learn more International Cancer Control Partnership (ICCP)The ICCP Portal is a one-stop shop for cancer prevention and control planning. It hosts selected resources on cancer control like toolkits, multimedia campaigns or background data.Learn more ResourcesAccess all resourcesTNM Classification of Malignant TumoursTNM Project StructurePublications and ResourcesE-learningHelpdeskEssential TNMCancer AtlasUICC JournalsIARC Cancer TodayReports on integrated cancer control in Latin America (ICCI-LA) Featured resources Information for cancer patients from Ukraine 6 April 2022 Access the resource World Cancer Leaders' Summit 2021 Report 16 November 2021 Access the resource 2020 Annual Report 21 July 2021 Access the resource About UICC - Leading the cancer community (Tri-fold leaflet) 2 September 2020 Access the resource Search Social live News and events over here! What's new Union for International Cancer ControlLeading theglobal fightagainst cancer   Union for International Cancer ControlUICC"The Union for International Cancer Control (UICC) unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda."Become a member 1205Members 172Countries 58Partners  Our main missions ConveningConvening the global cancer control community through our keystone eventsRead more Capacity BuildingDeveloping capacity building initiatives to strengthen the cancer communityRead more AdvocacyPromoting cancer in the global health and development agendasRead more Our key platforms 2022 World Cancer CongressLearn more 166days World Cancer Day 2023 – 4 FebLearn more 275days Latest news and updates Our news and updates 27 April 2022 News Efficient cancer control planning promotes greater equity in health In this month’s Let’s talk cancer, Dr Tsetse Batmunkh illustrates how cancer control can be integrated into national health schemes to promote Universal Health Coverage and ensure that everyone has access to care.  Read more 25 April 2022 News UICC Solidarity Fund for Ukraine opens call for grants to qualifying organisations Donations received for the UICC Solidarity Fund are being governed by an Advisory Board of experts and are now being made available to organisations in Ukraine and the region affected by the war. Read more 22 April 2022 News Tobacco is poisoning the environment as well as public health UICC is supporting World No Tobacco Day on 31 May – highlighting the detrimental impact of tobacco on the environment – with a collection of digital tools to promote more effective tobacco control. Read more 12 April 2022 Blog Cancer and ageing, a global opportunity for healthcare systems The increasing number of older adults with cancer represents both a challenge and an opportunity for improving healthcare systems worldwide. Read more More news and blog posts Spotlight on 22 September 2021 News The smokescreen of the tobacco industry's use of science Tobacco industry claims that it is moving away from harmful smoke products and investing in health care are undermined by conflicts of interest and the manipulation of information and science. Read more 15 February 2022 Blog Tobacco taxes are still one of the best tools to reduce cancer The recently released Tobacconomics Cigarette Tax Scorecard reveals a huge opportunity for countries to reap the public health benefits of improving tobacco taxation. Read more Upcoming events Event Master course: Future-proofing cancer organisations for uncertain and fast-changing times 9 May 2022 - 31 August 2022 Read more Event Master course: Raising the voices of patient advocates 9 May 2022 - 31 August 2022 Read more View more Featured Resources Information for cancer patients from Ukraine 6 April 2022 Access the resource 2020 Annual Report 21 July 2021 Access the resource About UICC - Leading the cancer community (Tri-fold leaflet) 2 September 2020 Access the resource World Cancer Leaders' Summit 2021 Report 16 November 2021 Access the resource View more resources News feed 29 April 2022 Indonesia takes an impressive step toward cervical cancer control Source: The National Tribune 28 April 2022 Zimbabwe's tobacco rebounds amid worries over health, labor Source: The Independent/AP 25 April 2022 Paid protesters, free lunches and backroom chats: inside the menthol lobbying machine Source: The Bureau of Investigative Journalism 1 of 3next › Our Partners Close partner description American Society for Clinical Pathology (ASCP) The American Society for Clinical Pathology (ASCP) is the world’s largest professional membership organisation for pathologists and laboratory professionals. In addition to their educational and certification missions around the world, they maintain a very active global health delivery program focused on laboratory strengthening in all aspects. Through their 10 year + work with PEPFAR, they have improved HIV-related testing and access in ~20 countries, trained more than 3000 individuals, and continue to deliver innovated diagnostics their partners. The Cancer Diagnostics and Treatment in Africa Initiative, created and led by ASCP, aims for 100% access to diagnostics for patients with cancer through on-site assessment, implementation planning, and, ultimately, connectivity to experts around the world through telepathology. With more than 100,000 members, the society’s influence has guided the application and evolution of the pathology and laboratory medicine specialty since 1922. ASCP is leading the way in global health pathology. Close partner description Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Close partner description Astellas The Astellas Group aims to become a R&D-driven global pharmaceutical company contributing to people’s health. Astellas’s business philosophy has three elements — raison d'être, mission and beliefs. This business philosophy expresses the company’s aim to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals, while continuously increasing the Company's enterprise value. Close partner description Beckton, Dickinson and Company Beckton, Dickinson and Company (BD) is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes. Close partner description Bristol-Myers Squibb (BMS) Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Close partner description Cancer Research UK Cancer Research UK is the world’s largest independent funder of cancer research. Its vision is to bring forward the day when all cancers are cured. Since 1902 CRUK has found new ways to prevent, diagnose and treat cancer. CRUK-funded scientists’ pioneered early radiotherapy, developed some of the world’s top cancer drugs and discovered the tumour suppressor gene, p53. Its work has saved millions of lives across the world. CRUK invests $500m annually in world-leading research across all 200 different types of cancer, working with partners in Europe, North America and Asia to accelerate research progress. It provides information to those affected by cancer, works to increase cancer awareness, and uses its powerful, independent voice to keep cancer at the top of the political agenda. CRUK funds some of the world’s leading experts in tobacco research and is a key player in international tobacco control. It became a full UICC member in 1986. Close partner description Cancerfonden Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research. Close partner description China Anti-Cancer Association (CACA) Established in 1984, the China Anti-Cancer Association (CACA) is a non-government and non-profit organisation with a mission to unite people involved in all branches of oncology with a shared interest in fighting cancer. CACA is dedicated to improving cancer control in China through increasing the survival rates, and decreasing the incidence and mortality rates of cancer. CACA plays an important role in promoting academic exchange, organising public education, establishing collaboration with international cancer societies, and providing data and advice to the Chinese government for making strategies and policies on cancer control. The branches consist of 45 professional societies, 47 full membership organisations, and 30 local anti-cancer associations with a total membership exceeding 47,000. Close partner description DKG Krebsgesellschaft The German Cancer Society (DKG) is the largest scientific and specialist oncology company in Germany with headquarters in Berlin. They are engaged in cancer care on the basis of evidence-based medicine, interdisciplinary and consequent quality standards. In total, DKG has about 7600 members, organised in 24 working groups, 16 regional cancer societies and 34 sponsors from research-based pharmaceutical industries, scientific publishers and health insurances. Since cancers need to be cross-treated and researched, their members are not only medical doctors of all sections, but also basic researchers, medical technical assistants, nurses, psychologists and other professionals who work on cancer.DKG specialises in certification of oncological care institutions, development of clinical practice guidelines, coordination of guidelines in the framework of the German Guideline Program of Oncology (GGPO), development and transfer of oncological knowledge, and improvement of information given to patients. Close partner description Fondation Philantropia An umbrella foundation associated with the bank Lombard Odier and a registered charity, Fondation Philanthropia has been helping its donors bring their philanthropic initiatives to fruition in all areas of social responsibility since 2008. It provides philanthropic expertise and support to those who wish to develop a philanthropic project in line with their background, desires and ambitions. The Foundation offers its donors a legal, financial and philanthropic framework for made-to-measure projects.The Foundation now operates more than 20 personal funds and has received over 115 million Swiss francs in donations, of which over a third has already been distributed or committed. Its donors have been highly committed to the fight against cancer, with over 15 million spent on the cause. Close partner description Hologic Close partner description ICON Group Icon Group is a leading provider of cancer care across Australasia. Icon believes in bringing the best cancer treatment possible, to as many people as possible, as close to home as possible. They do this through leveraging the latest technology, collaborating with like-minded partners and investing in outstanding people. Close partner description Institut National du Cancer The French National Cancer Institute (INCa) was established under the French Public Health Act of August 9, 2004, as the State health and science agency specialised in cancer control. The Institute operates under the supervision of the French Ministry of Health and Solidarities and the French Ministry of Higher Education, Research and Innovation. It provides an integrated approach encompassing all cancer-control aspects (health, scientific, social and economic) and intervention areas (prevention, screening, care, research) to benefit patients and their relatives. The Institute is also a trusted source of evidence-based information, providing reliable advice on cancer control to government and guidance to health professionals and the community. The Institute drives the implementation of the French decennial strategy against cancer (2021-2030): it plays a pivotal role in maximising coordination amongst cancer control stakeholders to enhance impact. Close partner description MSD (Merck & Co) For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases.  MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. Close partner description National Cancer Institute (NCI) The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients. Close partner description Novartis Oncology Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets. Close partner description Pfizer At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Close partner description Roche Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. Close partner description Sanofi Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life. Close partner description UICC Japan The Japan National Committee for UICC is a group of Japanese organisations that are members of the Union for International Cancer Control (UICC), gathered to support the UICC to strive to realise the World Cancer Declaration. Currently UICC-Japan is composed of 29 full Japanese UICC members, including major cancer specialists in Japan, cancer centres, research institutes, research funds, hospitals and cancer associations. View all Give usyour support Are you organising a cancer-related event and would like to feature it in our events section?Suggest an event Are you interested in joining a dynamic network of over 1,000 members?Become a member Would you like to support the work of UICC and its member organisations?Become a partner Join our mailing list Keep in touch with our latest updates Access our past newsletters View here Any questions? Contact us UICC PrivacyT&CCopyright Copyright © 2022 UICC.org Follow us TwitterLinkedInFacebookInstagram Who we areAbout UICCCancer controlAreas of workStrategyAnnual ReportsRecognition and awardsHistory of UICCUICC and TNMEquity and gender equality at UICCCEOBoard of DirectorsPresidentPresident-electThe TeamEmploymentHead of EventsHead of Partnership DevelopmentOther opportunitiesPress centreWhat we doConveningWorld Cancer DayWhy WCD MattersThe CampaignWorld Cancer Congress2022 World Cancer CongressPast CongressesWorld Cancer Leaders' Summit2021 World Cancer Leaders' SummitSummit ProgrammeSummit SpeakersOutstanding Contribution to Cancer Control AwardsShortlisted nominees2019 World Cancer Leaders' SummitSummit ProgrammeSide eventsOutstanding Contribution to Cancer Control AwardPast Summits2018 World Cancer Leaders' Summit2017 World Cancer Leaders' SummitOfficial Side Events2016 World Cancer Leaders' SummitHost a World Cancer Leaders' SummitRoundtable SeriesCalendar of cancer eventsVirtual DialoguesAgeing and Cancer seriesBreast Cancer seriesCancer beyond COVID-19 seriesCervical Cancer Elimination seriesLeading questions seriesRegional seriesTobacco Control and Cancer seriesPast Dialogues Resource HubCapacity BuildingGrantsBreast cancer grantsSPARC MBC ChallengeSelection Advisory GroupMetastatic Breast CancerSPARC mentorsFellowshipsVirtual FellowshipsTechnical FellowshipBourses pour l’Afrique FrancophoneYY Study GrantsFellowship Outcomes and ImpactAssociation of UICC FellowsPast successesLeadershipYoung Leaders programmeYoung Leaders 2021/2022Young Leaders 2019/2020Young Leaders AlumniOnline learningMaster coursesAdvocacy for improved cancer controlFuture-proofing cancer organisations for uncertain and fast-changing timesLaw and policy for cancer prevention and controlRaising the voices of patient advocatesSelf-guided coursesCancer Advocates programmePatient Group Mentoring programmeRegional engagementAdvocacyAdvocacy ImpactInteractive navigatorCancer planningWorld Cancer DeclarationWorking togetherGlobal Initiative for Childhood CancerIntegrated Cancer Control Initiative in Latin America (ICCI-LA)International Collaboration on Nutrition in relation to Cancer (ICONIC)UICC Advocacy NetworkAdvocacy resourcesThematic areas of workAntimicrobial resistanceUICC's actions on AMRAntimicrobial resistance resourcesBreast cancerUICC’s actions on breast cancerBreast cancer resourcesBreast Cancer ProgrammeCancer and AgeingCancer and COVID-19Cancer and COVID-19 resourcesCervical cancer eliminationUICC's actions on cervical cancerCervical cancer resourcesFinancing for cervical cancer eliminationEssential Medicines ListTobacco controlTobacco control resourcesWorld No Tobacco DayUniversal Health CoverageInvesting in cancer controlWho we work withMembersOur membership offerMembership categories and benefitsBecome a memberRenew membershipApply for membershipMap of membersGeneral Assembly2020 GAOn-line voting at UICC's first virtual General Assembly2020-2022 Board of Directors and President-elect candidates' profilesRecent Constitutional changesPast General AssembliesUICC AwardsUICC Awards: 2022 Best CEO AwardUICC Awards: 2022 Best WCD Campaign AwardUICC Awards: 2020 Winners and FinalistsUICC Awards: 2018 Winners and FinalistsUICC NewsletterMembers' CornerPartnersOur partnersPartners news and blog articlesPartner testimonialsBecome a partnerNetworksCity Cancer Challenge (C/Can)NCD AllianceInternational Cancer Control Partnership (ICCP)McCabe Centre for Law and CancerGlobal Initiative for Cancer Registries (GICR)UICC responding to the call to action to eliminate cervical cancerMembers response to call to action to eliminate cervical cancerResourcesAccess all resourcesTNM Classification of Malignant TumoursTNM Project StructurePublications and ResourcesE-learningHelpdeskEssential TNMCancer AtlasUICC JournalsIARC Cancer TodayReports on integrated cancer control in Latin America (ICCI-LA)